Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
October-2017 Volume 14 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2017 Volume 14 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma

  • Authors:
    • Ruhua Chen
    • Qingxiao Hong
    • Jianzhong Jiang
    • Xiaoying Chen
    • Zhenhuan Jiang
    • Jinzhi Wang
    • Shunlin Liu
    • Shiwei Duan
    • Shunbin Shi
  • View Affiliations / Copyright

    Affiliations: Department of Respiratory Medicine, Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu 214200, P.R. China, Laboratory of Behavioral Neuroscience, Ningbo Institute of Microcirculation and Henbane, Ningbo Addiction Research and Treatment Center, Ningbo, Zhejiang 315010, P.R. China, Department of Geriatrics, Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu 214200, P.R. China, Medical Genetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China, Department of Orthopaedics, Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu 214200, P.R. China, Department of Cell Biology, School of Medicine, Soochow University, Suzhou, Jiangsu 215000, P.R. China, Department of Respiratory Medicine, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China, Department of Thoracic Surgery, Affiliated Wujiang Hospital of Nantong University, Wujiang, Suzhou, Jiangsu 215000, P.R. China
  • Pages: 4989-4994
    |
    Published online on: August 25, 2017
       https://doi.org/10.3892/ol.2017.6824
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Aberrant DNA methylation is associated with non‑small cell lung cancer (NSCLC), suggesting that gene promoter methylation may be a potential biomarker for the detection or risk prediction of NSCLC. The present study aimed to evaluate the potential usage of angiotensin II receptor type 1 (AGTR1) methylation in two major pathologic subtypes: Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). Quantitative methylation‑specific polymerase chain reaction was used to investigate the effect of AGTR1 promoter methylation in the tumor and the paired adjacent non‑tumor tissue samples from 42 patients with LUSC, and 69 with LUAD. The percentage of methylated reference was calculated and presented as the median (interquartile range 25th‑75th percentile). The results of the current study revealed that there was significantly increased AGTR1 promoter methylation in the tumor tissues compared with the paired adjacent non‑tumor tissue [97.4 (57.22‑130.5) vs. 85 (48.25‑123); P=0.024]. Furthermore, higher AGTR1 promoter methylation was observed in patients with LUSC compared with LUAD (odds ratio=2.483; 95% confidence interval=1.125‑5.480; P=0.023). Significant differences were identified in AGTR1 methylation between non‑tumor and the tumor tissues in LUSC [113.5 (68.33‑148.73) vs. 93.04 (45.94‑140); P=0.008]. In addition, the Cancer Genome Atlas data of 378 patients with LUSC and 477 with LUAD revealed an inverse correlation between gene expression and the methylation status of AGTR1 promoter.. These data suggest that AGTR1 hypermethylation is a promising biomarker to assist in LUSC detection and diagnosis.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Barlési F, Giaccone G, Gallegos-Ruiz MI, Loundou A, Span SW, Lefesvre P, Kruyt FA and Rodriguez JA: Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol. 25:4358–4364. 2007. View Article : Google Scholar : PubMed/NCBI

2 

McGuire S: World cancer report 2014. Geneva, Switzerland: World health organization, international agency for research on cancer, WHO press, 2015. Adv Nutr. 7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Collins LG, Haines C, Perkel R and Enck RE: Lung cancer: Diagnosis and management. Am Fam Physician. 75:56–63. 2007.PubMed/NCBI

4 

NSCLC Meta-analysis Collaborative Group: Preoperative chemotherapy for non-small-cell lung cancer: A systematic review and meta-analysis of individual participant data. Lancet. 383:1561–1571. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Zhan C, Yan L, Wang L, Sun Y, Wang X, Lin Z, Zhang Y, Shi Y, Jiang W and Wang Q: Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma. J Thorac Dis. 7:1398–1405. 2015.PubMed/NCBI

6 

Hong Q, Li Y, Chen X, Ye H, Tang L, Zhou A, Hu Y, Gao Y, Chen R, Xia Y and Duan S: CDKN2B, SLC19A3 and DLEC1 promoter methylation alterations in the bone marrow of patients with acute myeloid leukemia during chemotherapy. Exp Ther Med. 11:1901–1907. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Yin D, Jia Y, Yu Y, Brock MV, Herman JG, Han C, Su X, Liu Y and Guo M: SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer. Discov Med. 14:33–40. 2012.PubMed/NCBI

8 

Haas U, Sczakiel G and Laufer SD: MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3′-UTR via altered RNA structure. RNA Biol. 9:924–937. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Tsygankova OM, Peng M, Maloney JA, Hopkins N and Williamson JR: Angiotensin II induces diverse signal transduction pathways via both Gq and Gi proteins in liver epithelial cells. J Cell Biochem. 69:63–71. 1998. View Article : Google Scholar : PubMed/NCBI

10 

Briet M, Barhoumi T, Mian MOR, Coelho SC, Ouerd S, Rautureau Y, Coffman TM, Paradis P and Schiffrin EL: Aldosterone-induced vascular remodeling and endothelial dysfunction require functional angiotensin type 1a receptors. Hypertension. 67:897–905. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Fan R, Mao S, Zhong F, Gong M, Yin F, Hao L and Zhang L: Association of AGTR1 promoter methylation levels with essential hypertension risk: A matched case-control study. Cytogenet Genome Res. 147:95–1029. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN Jr, Frederick MJ, Wang J, Lang W, Feng L, et al: New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prev Res (Phila). 8:1027–1035. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF, et al: DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res (Phila). 6:656–665. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Rhodes DR, Ateeq B, Cao Q, Tomlins SA, Mehra R, Laxman B, Kalyana-Sundaram S, Lonigro RJ, Helgeson BE, Bhojani MS, et al: AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist. Proc Natl Acad Sci USA. 106:10284–10289. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Bi FF, Li D, Cao C, Li CY and Yang Q: Regulation of angiotensin II type 1 receptor expression in ovarian cancer: A potential role for BRCA1. J Ovarian Res. 6:892013. View Article : Google Scholar : PubMed/NCBI

16 

Du N, Feng J, Hu LJ, Sun X, Sun HB, Zhao Y, Yang YP and Ren H: Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol Rep. 27:1893–1903. 2012.PubMed/NCBI

17 

Guo S, Yan F, Xu J, Bao Y, Zhu J, Wang X, Wu J, Li Y, Pu W, Liu Y, et al: Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC). Clin Epigenetics. 7:32015. View Article : Google Scholar : PubMed/NCBI

18 

Lewis SZ, Diekemper R and Addrizzo-Harris DJ: Methodology for development of guidelines for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest Physicians evidence-based clinical practice guidelines. Chest. 143 (5 Suppl):41S–50S. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Hughes S and Jones JL: The use of multiple displacement amplified DNA as a control for methylation specific PCR, pyrosequencing, bisulfite sequencing and methylation-sensitive restriction enzyme PCR. BMC Mol Biol. 8:912007. View Article : Google Scholar : PubMed/NCBI

20 

Salvador J, Manso L, de la Haba J, Jaen A, Ciruelos E, de Villena MC, Gil M, Murias A, Galan A, Jara C, et al: Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Clin Transl Oncol. 17:160–166. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Koch A, De Meyer T, Jeschke J and Van Criekinge W: MEXPRESS: Visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 16:6362015. View Article : Google Scholar : PubMed/NCBI

22 

Namazi S, Sahebi E, Rostami-Yalmeh J, Jaberipour M, Razmkhah M, Hosseini A and Arabsolghar R: Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells. Tumour Biol. 36:893–900. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Alhusban A, Al-Azayzih A, Goc A, Gao F, Fagan SC and Somanath PR: Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis. J Pharmacol Exp Ther. 350:635–645. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Chen X, Meng Q, Zhao Y, Liu M, Li D, Yang Y, Sun L, Sui G, Cai L and Dong X: Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer. Cancer Lett. 328:318–324. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Zhang C, Zhao H, Li J, Liu H, Wang F, Wei Y, Su J, Zhang D, Liu T and Zhang Y: The identification of specific methylation patterns across different cancers. PLoS One. 10:e01203612015. View Article : Google Scholar : PubMed/NCBI

26 

Word B, Lyn-Cook LE Jr, Mwamba B, Wang H, Lyn-Cook B and Hammons G: Cigarette smoke condensate induces differential expression and promoter methylation profiles of critical genes involved in lung cancer in NL-20 lung cells in vitro: Short-term and chronic exposure. Int J Toxicol. 32:23–31. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Lyn-Cook L, Word B, George N, Lyn-Cook B and Hammons G: Effect of cigarette smoke condensate on gene promoter methylation in human lung cells. Tob Induc Dis. 12:152014. View Article : Google Scholar : PubMed/NCBI

28 

Chen K, Wang PP, Sun B, Li Q, Perruccio A, Power D, Wang C, He MMH, Shibei Y, et al: Twenty-year secular changes in sex specific lung cancer incidence rates in an urban Chinese population. Lung Cancer. 51:13–19. 2006. View Article : Google Scholar : PubMed/NCBI

29 

Isla D, Majem M, Viñolas N, Artal A, Blasco A, Felip E, Garrido P, Remón J, Baquedano M, Borrás JM, et al: A consensus statement on the gender perspective in lung cancer. Clin Transl Oncol. 19:527–535. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Urvay SE, Yucel B, Erdis E and Turan N: Prognostic factors in stage III non-small-cell lung cancer patients. Asian Pac J Cancer Prev. 17:4693–4697. 2016.PubMed/NCBI

31 

Campoy EM, Laurito SR, Branham MT, Urrutia G, Mathison A, Gago F, Orozco J, Urrutia R, Mayorga LS and Roqué M: Asymmetric cancer hallmarks in breast tumors on different sides of the body. PLoS One. 11:e01574162016. View Article : Google Scholar : PubMed/NCBI

32 

Perkins CI, Hotes J, Kohler BA and Howe HL: Association between breast cancer laterality and tumor location, United States, 1994–1998. Cancer Causes Control. 15:637–645. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Sykes SD, Mitchell C, Pringle KG, Wang Y, Zakar T and Lumbers ER: Methylation of promoter regions of genes of the human intrauterine Renin Angiotensin system and their expression. Int J Endocrinol. 2015:4598182015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen R, Hong Q, Jiang J, Chen X, Jiang Z, Wang J, Liu S, Duan S and Shi S: AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma. Oncol Lett 14: 4989-4994, 2017.
APA
Chen, R., Hong, Q., Jiang, J., Chen, X., Jiang, Z., Wang, J. ... Shi, S. (2017). AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma. Oncology Letters, 14, 4989-4994. https://doi.org/10.3892/ol.2017.6824
MLA
Chen, R., Hong, Q., Jiang, J., Chen, X., Jiang, Z., Wang, J., Liu, S., Duan, S., Shi, S."AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma". Oncology Letters 14.4 (2017): 4989-4994.
Chicago
Chen, R., Hong, Q., Jiang, J., Chen, X., Jiang, Z., Wang, J., Liu, S., Duan, S., Shi, S."AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma". Oncology Letters 14, no. 4 (2017): 4989-4994. https://doi.org/10.3892/ol.2017.6824
Copy and paste a formatted citation
x
Spandidos Publications style
Chen R, Hong Q, Jiang J, Chen X, Jiang Z, Wang J, Liu S, Duan S and Shi S: AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma. Oncol Lett 14: 4989-4994, 2017.
APA
Chen, R., Hong, Q., Jiang, J., Chen, X., Jiang, Z., Wang, J. ... Shi, S. (2017). AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma. Oncology Letters, 14, 4989-4994. https://doi.org/10.3892/ol.2017.6824
MLA
Chen, R., Hong, Q., Jiang, J., Chen, X., Jiang, Z., Wang, J., Liu, S., Duan, S., Shi, S."AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma". Oncology Letters 14.4 (2017): 4989-4994.
Chicago
Chen, R., Hong, Q., Jiang, J., Chen, X., Jiang, Z., Wang, J., Liu, S., Duan, S., Shi, S."AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma". Oncology Letters 14, no. 4 (2017): 4989-4994. https://doi.org/10.3892/ol.2017.6824
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team